Peritoneal Neoplasms: Clinical Trials

2 trials for Peritoneal Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1

Follow Peritoneal Neoplasms: new trials by email Literature Review of Peritoneal Neoplasms trials Research Report on Peritoneal Neoplasms

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
complete cytoreductive surgery plus HIPEC with Mytomicin C for 90 minutes, complete cytoreductive surgery without HIPEC - Peritoneal Carcinomatosis, Colon Cancer
Phase 4RecruitingHospital Universitario de Fuenlabrada2162022-03-022024-10-09
An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Bevacizumab - Ovarian Neoplasms, Peritoneal Neoplasms
Phase 4CompletedHoffmann-La Roche1002018-12-052025-06-26

Narrower conditions

Colonic Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Ovarian Neoplasms (1)

Broader conditions

Abdominal Neoplasms (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Peritoneal Diseases (2)  ·  Adnexal Diseases (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Fallopian Tube Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)

Interventions

Bevacizumab (1)  ·  Hyperthermic Intraperitoneal Chemotherapy (1)

Sponsors

Hoffmann-La Roche (1)  ·  Hospital Universitario de Fuenlabrada (1)

Countries

India (1)  ·  Spain (1)

Top investigators

Fernando Pereira, PhD (1)

Results publications

PMID 35549912

NIH funding

2019 (1)